BELLUS Health EV - Enterprise Value 2011-2026 | BLU

Annual EV - Enterprise Value BELLUS Health

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-70.4 M	395 M	183 M	397 M	119 M	24.8 M	13.5 M	39.3 M	50.3 M	31.5 M	28.7 M	60.8 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
397 M	-70.4 M	106 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
AbCellera Biologics ABCL	1.22 B	$ 3.55	-0.28 %	$ 1.06 B	Canada
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
AC Immune SA ACIU	82.4 M	$ 3.25	3.67 %	$ 229 M	Schweiz
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	33.1 M	-	10.36 %	$ 9.8 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
ADC Therapeutics SA ADCT	114 M	$ 4.14	-1.9 %	$ 105 M	Schweiz
Aptorum Group Limited APM	9.45 M	$ 0.79	-	$ 4.31 M	China
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
Arcturus Therapeutics Holdings ARCT	43.4 M	$ 6.58	-0.75 %	$ 180 M	Israel
argenx SE ARGX	-796 M	$ 710.26	0.99 %	$ 25 B	Niderland
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Alterity Therapeutics Limited ATHE	-28.9 M	$ 3.43	-4.99 %	$ 8.25 B	Australia
Ascendis Pharma A/S ASND	849 M	$ 229.93	-0.47 %	$ 5 B	Danmark
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Atea Pharmaceuticals AVIR	370 M	$ 6.09	0.58 %	$ 496 M	USA
BioCardia BCDA	12.4 M	$ 1.31	2.91 %	$ 27.7 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Athersys ATHX	-37.4 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Allena Pharmaceuticals ALNA	-14.1 M	-	3.16 %	$ 1.9 M	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
AlloVir ALVR	-64.1 M	-	4.14 %	$ 49.1 M	USA
Can-Fite BioPharma Ltd. CANF	647 M	$ 3.47	-3.07 %	$ 7.55 B	Israel
Catalyst Biosciences CBIO	986 M	$ 11.19	-3.41 %	$ 1 B	USA
Anika Therapeutics ANIK	300 M	$ 14.61	1.74 %	$ 214 M	USA
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Aptose Biosciences APTO	10.8 M	-	-45.71 %	$ 1.2 M	Canada
AVEO Pharmaceuticals AVEO	86.9 M	-	-	$ 521 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
CNS Pharmaceuticals CNSP	-3.42 M	$ 2.36	-3.55 %	$ 902 K	USA
Aytu BioScience AYTU	-15.2 M	$ 2.62	-0.75 %	$ 16.5 M	USA
Avenue Therapeutics ATXI	-1.23 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	1.11 B	$ 1.51	-	$ 385 M	Britain
BioNTech SE BNTX	-4.91 B	$ 93.66	3.45 %	$ 27.2 B	Germany
Athira Pharma ATHA	-18.3 M	-	-	$ 269 M	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA